Case Investigations

PayPal Holdings, Inc.

April 29, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating PayPal Holdings, Inc. ("PayPal” or the "Company") (NASDAQ: PYPL) for potential violations of the federal securities laws.  Investors who purchased shares of PayPal common stock may be affected.

First NBC Bank Holding Company

April 11, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating First NBC Bank Holding Company ("FNBC” or the "Company") (NASDAQ: FNBC) for potential violations of the federal securities laws.  Investors who purchased shares of FNBC common stock since the Company’s May 9, 2013 initial public offering (“IPO”) may be affected.

Natus Medical Incorporated

April 10, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Natus Medical Incorporated (“Natus” or the "Company") (Nasdaq: BABY).  Investors who purchased Natus securities between October 15, 2015 and April 1, 2016 may be affected.

Vericel Corporation

April 5, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Vericel Corporation (“Vericel” or the "Company") (Nasdaq: VCEL).  Investors who purchased Verical securities between March 10, 2016 and April 1, 2016 may be affected.

Restoration Hardware Holdings, Inc.

April 5, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Restoration Hardware Holdings, Inc. (“RH” or the "Company") (NYSE: RH).  Investors who purchased RH securities between October 12, 2015 and February 24, 2016 may be affected.

MFC Bancorp Ltd.

March 31, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating MFC Bancorp Ltd. (“MFC” or the “Company”) (NYSE: MFCB) on behalf of investors who purchased MFC securities.

LPL Financial Holdings Inc.

March 30, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating LPL Financial Holdings Inc. (“LPL” or the “Company”) on behalf of investors who purchased LPL securities between December 8, 2015 and February 11, 2016.

Fly Leasing Limited

March 30, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Fly Leasing Limited (“Fly Limited” or the “Company”) on behalf of investors who purchased Fly Limited securities between May 8, 2014 and March 7, 2016.

PJT Partners, Inc.

March 28, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating PJT Partners Inc. (“PJT” or the "Company") (NYSE: PJT).  Investors who purchased PJT securities between October 1, 2015 and March 24, 2016 may be affected.

Amaya, Inc.

March 23, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Amaya, Inc. (“Amaya” or the "Company") (Nasdaq: AYA).  Investors who purchased Amaya securities between May 28, 2014 and March 22, 2016 may be affected.

GAIN Capital Holdings, Inc.

March 16, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating GAIN Capital Holdings, Inc. (“Gain” or the "Company") (NYSE: GCAP).  Investors who purchased Gain securities between February 27, 2014 and March 15, 2016 may be affected.

Santander Consumer USA Holdings Inc.

March 16, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Santander Consumer USA Holdings Inc. (“Santander” or the "Company") (NYSE: SC).  Investors who purchased Santander securities between February 2, 2015 and March 15, 2016 may be affected.

Alere Inc.

March 16, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Waltham, Massachusetts-based Alere Inc. (“Alere” or the "Company").

Aequitas Management LLC

March 10, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Oregon-based Aequitas Management LLC (“Aequitas” or the "Company").  On March 10, 2016, the U.S. Securities and Exchange Commission (“SEC”) charged Aequitas and three senior executives “with hiding the rapidly deteriorating financial condition of its enterprise while raising more than $350 million from investors."

Tangoe, Inc.

March 8, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Tangoe, Inc. ("Tangoe” or the "Company") (NASDAQ: TNGO) for potential violations of the federal securities laws.  Investors who purchased shares of Tangoe common stock between May 9, 2013 and March 7, 2016 may be affected.

Herbalife Ltd.

March 4, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Herbalife Ltd. ("Herbalife” or the "Company") (NYSE: HLF) for potential violations of the federal securities laws.  Investors who purchased shares of Herbalife common stock between August 5, 2015 and March 2, 2016 may be affected.

Third Avenue Management LLC

February 9, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Third Avenue Management LLC, Third Avenue Trust (“Third Avenue” or the “Trust”), and the Third Avenue Focused Credit Fund ( or the “Fund”) for potential violations of the securities laws.  Investors who purchased either Institutional or Investor shares of the Fund (NASDAQ: TCFIX or TFCVX) from March 1, 2013 through December 10, 2015 (the “Class Period”) may be affected.

Match Group, Inc.

February 3, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Match Group, Inc. (“Match” or the “Company”) (Nasdaq: MTCH) for potential violations of the federal securities laws.  Investors who purchased the Company’s common stock since the Company’s initial public offering of common stock on November 18, 2015 at $12 per share on may be affected.

Ooma Inc.

January 25, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Ooma Inc. ("Ooma” or the "Company") (NYSE: OOMA) for potential violations of the federal securities laws.  Investors who purchased Ooma common stock since the Company’s July 17, 2015 Initial Public Offering (the “IPO”)  may be affected.

Cnova NV

January 25, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Cnova NV ("Cnova” or the "Company") (Nasdaq: CNV) for potential violations of the federal securities laws.  Investors who purchased Cnova securities may be affected.

Sarepta Therapeutics

January 15, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Sarepta Therapeutics Inc. ("Sarepta” or the "Company") (Nasdaq: SRPT) for potential violations of the federal securities laws.  Investors who purchased shares of Sarepta common stock may be affected.

GoPro Inc.

January 14, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating GoPro Inc. (“GoPro” or the “Company”) (Nasdaq: GPRO) for potential violations of the federal securities laws.  Investors who purchased Company securities between July 21, 2015 and January 13, 2016 may be affected.

Fifth Street Asset Management, Inc.

January 12, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Fifth Street Asset Management, Inc. (“FSAM” or the “Company”) (NASDAQ: FSAM).  FSAM is a credit-focused asset manager and the investment advisor for Fifth Street Finance Corp. (“FSC”), Fifth Street Senior Floating Rate Corp. (“FSFR”), and various private Fifth Street funds. Investors who purchased shares of FSAM common stock in the Company’s October 29, 2014 initial public offering (“IPO”) or since the IPO may be affected.

Anavex Life Sciences Corporation

December 29, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Anavex Life Sciences Corporation (“Anavex” or the “Company”) (Nasdaq: AVXL) for potential violations of the federal securities laws.  Investors who purchased Company securities between October 25, 2015 and December 28, 2015 may be affected.

KaloBios Pharmaceuticals, Inc.

December 21, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating KaloBios Pharmaceuticals, Inc. ("KaloBios” or the “Company”) (NASDAQ: KBIO) for potential violations of the federal securities laws.  Investors who purchased KaloBios’ common stock may be affected.

Neothetics, Inc.

December 15, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Neothetics, Inc. (“Neothetics” or the “Company”) (NASDAQ: NEOT).  Neothetics is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The Company’s lead product candidate, LIPO-202, is for the reduction of subcutaneous fat in the central abdomen (belly fat) in non-obese patients.  Investors who purchased shares of Neothetics common stock in the Company’s initial public offering (“IPO”) or since the IPO may be affected.

Barnes & Noble Education, Inc.

December 11, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Barnes & Noble Education, Inc. ("Barnes & Noble Education” or the "Company") (NYSE: BNED) for potential violations of the federal securities laws.  Investors who acquired or purchased Barnes & Noble Education securities since the Company’s August 2015 spin-out from Barnes &  Noble, Inc. (“Barnes & Noble”) may be affected.

United Development Funding IV

December 11, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating United Development Funding IV ("UDF IV" or the "Company") (Nasdaq: UDF), a Real Estate Investment Trust ("REIT"), for potential violations of the federal securities laws.  Investors who purchased UDF IV securities may be affected.

XBiotech, Inc.

November 24, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating XBiotech, Inc. ("XBiotech” or the "Company") (Nasdaq: XBIT) for potential violations of the federal securities laws.  Investors who purchased XBiotech securities since the Company’s April 14, 2015 initial public offering (“IPO”) may be affected.

Checkpoint Systems, Inc.

November 3, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Checkpoint Systems, Inc.. ("Checkpoint” or the "Company") (NYSE: CKP) for potential violations of the federal securities laws.  Investors who purchased Checkpoint securities may be affected.